FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
-
-
-
-
-
-
-
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
-
-
-
-
-
-
-
FDA advances psychedelic drug studies for mental health treatment
-
-
-
-
-
-
-
Compass Pathways launches grant program for COMP360 provider training
-
-
-
-
-
-
-
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights
-
-
-
-
-
-
-
Compass Pathways Announces Pricing of $150 Million Public Offering
-
-
-
-
-
-
-
Compass Pathways Announces FDA Acceptance of IND Application for PTSD
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

